Analyzing 454,098 UK Biobank participants, researchers discovered that people with genetically shorter telomeres are significantly more likely to develop clonal hematopoiesis (CH) driven by splicing factor mutations—as well as mutations in PPM1D and the TERT promoter. The study proposes that as telomeres shorten with age, most hematopoietic stem cells (HSCs) lose their competitive fitness, but HSCs harboring splicing factor mutations gain a survival advantage by tolerating or compensating for critical telomere attrition. This positions telomere erosion as an active selective pressure—not merely a passive aging hallmark—that shapes which mutant clones come to dominate blood production and potentially progress to myeloid malignancies.
